Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8733614 | Critical Reviews in Oncology/Hematology | 2018 | 8 Pages |
Abstract
Only a few models have been developed to predict endometrial cancer in asymptomatic or symptomatic women. The usefulness of most models is unclear considering methodological shortcomings and lack of external validation. Future research should focus on external validation and extension with new predictors or biomarkers, such as genetic and epigenetic markers.
Related Topics
Health Sciences
Medicine and Dentistry
Hematology
Authors
Maaike Alblas, Kimberley B. Velt, Nora Pashayan, Martin Widschwendter, Ewout W. Steyerberg, Yvonne Vergouwe,